Reconsidering the revised amyotrophic lateral sclerosis functional rating scale for ALS clinical trials
J Neurol Neurosurg Psychiatry
.
2021 May;92(5):569-570.
doi: 10.1136/jnnp-2020-325253.
Epub 2020 Nov 23.
Authors
Adriaan D de Jongh
1
,
Leonard H van den Berg
1
,
Ruben P A van Eijk
2
3
Affiliations
1
Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
2
Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands R.P.A.vanEijk-2@umcutrecht.nl.
3
Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
PMID:
33229452
DOI:
10.1136/jnnp-2020-325253
No abstract available
Keywords:
ALS; motor neuron disease; randomised trials.
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Amyotrophic Lateral Sclerosis / diagnosis*
Clinical Trials as Topic
Disability Evaluation*
Humans